Two major Smad pathways in TGF-β superfamily signalling

Genes to Cells

Volumn 7, Issue 12, 2002, Pages 1191-1204

  Miyazawa, Keiji ^a   Shinozaki, Masahiko ^a   Hara, Takane ^b   Furuya, Toshio ^b   Miyazono, Kohei ^a,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b PharmaDesign Inc   (Japan)

^c CANCER INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; INHIBIN; INHIBITOR PROTEIN; MYOSTATIN; OSTEOGENIC PROTEIN 1; OSTEOGENIN; PROTEIN SERINE THREONINE KINASE; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

CELL NUCLEUS; COMPLEX FORMATION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; INTRACELLULAR TRANSPORT; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; DNA-BINDING PROTEINS; HUMANS; MODELS, MOLECULAR; MULTIGENE FAMILY; PHYLOGENY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

MAMMALIA;

EID: 0036910425     PISSN: 13569597     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2443.2002.00599.x     Document Type: Review

References (136)

1. Adachi, J. & Hasegawa, M. (1996) MOLPHY, version 2.3: Programs for molecular phylogenetics based on maximum likelihood. Computer Science Monographs 28. Institute of Statistical Mathematics, Tokyo.
2. Akiyoshi, S., Inoue, H., Hanai J-i., et al. (1999) c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with Smads. J. Biol. Chem. 274, 35269-35277.
3. Aoki, H., Fujii, M., Imamura, T., et al. (2001) Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. J. Cell Sci. 114, 1483-1489.
4. Bai, R.-Y., Koester, C., Ouyang, T., et al. (2002) SMIF, a Smad4-interacting protein that functions as a co-activator in TGFβ signaling. Nature Cell Biol. 4, 181-191.
5. Bai, S., Shi, X., Yang, X. & Cao, X. (2000) Smad6 as a transcriptional corepressor. J. Biol. Chem. 275, 8267-8270.
6. Bernard, D.J., Chapman, S.C. & Woodruff, T.K. (2002) Inhibin binding protein (InhBP/p120), betaglycan, and the continuing search for the inhibin receptor. Mol. Endocrinol. 16, 207-212.
7. Blobe, G.C., Schiemann, W.P. & Lodish, H.F. (2000) Role of transforming growth factor-β in human disease. N. Engl. J. Med. 342, 1350-1358.
8. Blokzijl, A., ten Dijke, P. & Ibañez, C.F. (2002) Physical and functional interaction between GATA-3 and Smad3 allows TGF-β regulation of GATA target genes. Curr. Biol. 12, 35-45.
9. Chen, C.-R., Kang, Y. & Massagué, J. (2001) Defective repression of c-myc in breast cancer cells: a loss at the core of the transforming growth factor growth-β arrest program. Proc. Natl. Acad. Sci. USA 98, 992-999.
10. Chen, C.-R., Kang, Y., Siegel, P.M. & Massagué, J. (2002a) E2F4/5 and p107 as Smad cofactors linking the TGFβ receptor to c-myc repression. Cell 110, 19-32.
11. Chen, F., Ogawa, K., Liu, X., Stringfield, T.M. & Chen, Y. (2002b) Repression of Smad2 and Smad3 transactivating activity by association with a novel splice variant of CCAAT-binding factor C subunit. Biochem. J. 364, 571-577.
12. Chen, X., Weisberg, E., Fridmacher, V., Watanabe, M., Naco, G. & Whitman, M. (1997) Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389, 85-89.
13. Chipuk, J.E., Cornelius, S.C., Pultz, N.J., et al. (2002) The androgen receptor represses transforming growth factor-β signaling through interaction with Smad3. J. Biol. Chem. 277, 1240-1248.
14. Clarke, T.R., Hoshiya, Y., Yi, S.E., Liu, X., Lyons, K.M. & Donahoe, P.K. (2001) Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces Smad6 expression. Mol. Endocrinol. 15, 946-959.
15. Daluiski, A., Engstrand, T., Bahamonde, M.E., et al. (2001) Bone morphogenetic protem-3 is a negative regulator of bone density. Nature Genet. 27, 84-88.
16. Datta, P.K., Blake, M.C. & Moses, H.L. (2000) Regulation of plasminogen activator inhibitor-1 expression by transforming growth factor-β induced physical and functional interactions between Smads and Sp1. J. Biol. Chem. 275, 40014-40019.
17. Datta, P.K. & Moses, H.L. (2000) STRAP and Smad7 synergize in the inhibition of transforming growth factor-β signaling. Mol. Cell. Biol. 20, 3157-3167.
18. Datto, M.B., Frederick, J.P., Pan, L., Borton, A.J., Zhuang, Y. & Wang, X.-F. (1999) Targeted disruption of smad3 reveals an essential role in transforming growth factor β-mediated signal transduction. Mol. Cell. Biol. 19, 2495-2504.
19. Dennler, S., Itoh, S., Vivien, D., ten Dijke, P., Huet, S. & Gauthier, J. M. (1998) Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17, 3091-3100.
20. Dong, C., Li, Z., Alvarez, R. Jr, Feng, X.-H. & Goldschmidt-Clermont, P.J. (2000) Microtubule binding to Smads may regulate TGFβ activity. Mol. Cell 5, 27-34.
21. Ebisawa, T., Fukuchi, M., Murakami G., et al. (2001) Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem. 276, 12477-12480.
22. Ink4B. Mol. Cell 9, 133-143.
23. Ink4B transcription in response to TGF-β. EMBO J. 19, 5178-5193.
24. Feng, X.-H., Zhang, Y, Wu, R.Y. & Derynck, R. (1998) The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation. Genes Dev. 12, 2153-2163.
25. Ferrigno, O., Lallemand, F., Verrecchia, F., et al. (2002) Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-β/Smad signaling. Oncogene 21, 4879-4884.
26. Fu, M., Zhang, J., Zhu, X., et al. (2001) Peroxisome proliferator-activated receptor γ inhibits transforming growth factor β-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3. J. Biol. Chem. 276, 45888-45894.
27. Fukuchi, M., Imamura, T., Chiba, T., et al. (2001) Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. Mol. Biol. Cell 12, 1431-1443.
28. Furuhashi, M., Yagi, K., Yamamoto, H., et al. (2001) Axin facilitates Smad3 activation in the transforming growth factor β signaling pathway. Mol. Cell. Biol. 21, 5132-5141.
29. Germain, S., Howell, M., Esslemont, G.M. & Hill, C.S. (2000) Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif. Genes Dev. 14, 435-451.
30. Gouédard, L., Chen, Y.-G., Thevenet, L., et al. (2000) Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor. J. Biol. Chem. 275, 27973-27978.
31. Goumans, M.-J., Valdimarsdottir, G., Itoh, S., Rosendahl, A., Sideras, P. & ten Dijke, P. (2002) Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J. 21, 1743-1753.
32. Hahn, S.A., Schutte, M., Hoque, A.T.M.S., et al. (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q2l. 1. Science 271, 350-353.
33. Hanai, J.-i., Chen, L.F., Kanno, T, et al. (1999) Interaction and functional cooperation of PEBP2/CBF with Smads: Synergistic induction of the immunoglobulin germline Cα promoter. J. Biol. Chem. 274, 31577-31582.
34. Hanyu, A., Ishidou, Y., Ebisawa, T., Shimanuki, T., Imamura, T. & Miyazono,K. (200t) The N-domain of Smad7 is essential for specific inhibition of transforming growth factor-β signaling. J. Cell Biol. 155, 1017-1028.
35. Hata, A., Seoane, J., Lagna, G., Montalvo, E., Hemmati-Brivanlou, A. & Massagué, J. (2000) OAZ uses distinct DNA-and protein-binding Zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell 100, 229-240.
36. Heldin, C.-H., Miyazono, K. & ten Dijke, P. (1997) TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
37. Henningfeld, K.A., Friedle, H., Rastegar, S. & Knöchel, W (2002) Autoregulation of Xvent-2B; direct interaction and functional cooperation of Xvent-2 and Smad1. J. Biol. Chem. 277, 2097-2103.
38. Hocevar, B.A., Smine, A., Xu, X.-X. & Howe, P.H. (2001) The adaptor molecule Disabled-2 links the transforming growth factor-β receptors to the Smad pathway. EMBO J. 20, 2789-2801.
39. Hua, X., Miller, Z.A., Wu, G., Shi, Y. & Lodish, H.F. (1999) Specificity in transforming growth factor β-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor μE3, and Smad proteins. Proc. Natl. Acad. Sci. USA 96, 13130-13135.
40. Inman, G.J., Nicolas, F.J., Callahan, J. F., et al. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62, 65-74.
41. Ishida, W., Hamamoto, K., Kusanagi, K., et al. (2000) Smad6 is a Smad1/5-induced Smad inhibitor: Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter. J. Biol. Chem. 275, 6075-6079.
42. Itoh, F., Asao, H., Sugamura, K., Heldin, C.-H., ten Dijke, P. & Itoh, S. (2001) Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads. EMBO J. 20, 4132-4142.
43. Itoh, S., Ericsson, J., Nishikawa J., Heldin, C.-H. & ten Dijke, P. (2000) The transcriptional co-activator P/CAF potentiates TGF-β/Smad signaling. Nucl. Acids Res. 28, 4291-4298.
44. Janknecht, R., Wells, N.J. & Hunter, T. (1998) TGF-β-stimulated cooperation of Smad proteins with the coactivators CBP/p300. Genes Dev. 12, 2114-2119.
45. Jonk, L.J., Itoh, S., Heldin, C.-H., ten Dijke, P. & Kruijer, W. (1998) Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-β, activin, and bone morphogenetic protein-inducible enhancer. J. Biol. Chem. 273, 21145-21152.
46. Kaji, H., Canaff, L., Lebrun, J.-J., Goltzman, D. & Hendy, G.N. (2001) Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type β signaling. Proc. Natl. Acad. Sci. USA 98, 3837-3842.
47. Kang, H.-Y., Lin, H.-K., Hu, Y-C., Yeh, S. & Chang, C. (2001) From transfortning growth factor-β signaling to androgen action: Identification of Smad3 as an androgen receptor coregulator in prostate cancer cells. Proc. Natl. Acad. Sci. USA 98, 3018-3023.
48. Kardassis, D., Pardali, K. & Zannis, V.I. (2000) Smad proteins transactivate the human ApoC III promoter by interacting physically and functionally with hepatocyte nuclear factor 4. J. Biol. Chem. 275, 41405-41414.
49. Kato, Y., Habas, R., Katsuyama, Y., Näär, A.M. & He, X. (2002) A component of the ARC/Mediator complex required for TGFβ/Nodal signaling. Nature 418, 641-646.
50. Kavsak, P., Rasmussen, R.K., Causing, C.G., et al. (2000) Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation. Mol. Cell 6, 1365-1375.
51. Kawabata, M., Imamura, T. & Miyazono, K. (1998a) Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev. 9, 49-61.
52. Kawabata, M., Inoue, H., Hanyu, A., Imamura, T. & Miyazono, K. (1998b) Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J. 17, 4056-4065.
53. Kim, R.H., Wang, D., Tsang, M., et al. (2000) A novel Smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-β signal transduction. Genes Dev. 14, 1605-1616.
54. Kimura, N., Matsuo, R., Shibuya, H., Nakashima, K. & Taga, T. (2000) BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J. Biol. Chem. 275, 17647-17652.
55. Kirsch, T., Sebald, W. & Dreyer, M.K. (2000) Crystal structure of the BMP-2-BRIA ectodomain complex. Nature Struct. Biol. 7, 492-496.
56. Kurisaki, A., Kose, S., Yoneda, Y., Heldin, C.-H. & Moustakas, A. (2001) Transforming growth factor-β induces nuclear import of Smad3 in an importin-β1 and Ran-dependent manner. Mol. Biol. Cell 12, 1079-1091.
57. Kurokawa, M., Mitani, K., Irie, K., et al. (1998) The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3. Nature 394, 92-96.
58. Kusanagi, K., Kawabata, M., Mishima, H.K. & Miyazono, K. (2001) α-Helix 2 in the amino-terminal Mad homology 1 domain is responsible for specific DNA-binding of Smad3. J. Biol. Chem. 276, 28155-28163.
59. Labbé, E., Letamendia, A. & Attisano, L. (2000) Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-β and Wnt pathways. Proc. Natl. Acad. Sci. USA 97, 8358-8363.
60. Labbé, E., Silvestri, C., Hoodless, P.A., Wrana, J.L. & Attisano, L. (1998) Smad2 and Smad3 positively and negatively regulate TGFβ-dependent transcription through the forkhead DNA-binding protein FAST2. Mol. Cell 2, 109-120.
61. Laping, N.J., Grygielko, E., Mathur, A., et al. (2002) Inhibition of transforming growth factor (TGF) β-1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity: SB-431542. Mol. Pharmacol. 62, 58-64.
62. Lee, D.K., Kim, B.-C., Brady, J.N., Jeang, K.-T. & Kim, S.J. (2002a) Human T-cell lymphotropic virus 1-Tax inhibits TGF-β signaling by blocking the association of Smad proteins with Smad binding element. J. Biol. Chem. 277, 33766-33775.
63. Lee, D.K., Kim, B.-C., Kim, I.Y., Cho, E.-A., Satterwhite, D.J. & Kim, S.-J. (2002b) The human papilloma virus E7 oncoprotein inhibits TGF-β signaling by blocking of the Smad complex to its target sequence. J. Biol. Chem. 277, 38557-38564.
64. Lee, D.K., Park, S.H., Yi, Y., et al. (2001) The hepatitis B virus encoded oncoprotein pX amplifies TGF-β family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev. 15, 455-466.
65. Leong, G.M., Subramaniam, N., Figueroa, J., et al. (2001) Ski-interacting protein interacts with Smad proteins to augment transforming growth factor-β-dependent transcription. J. Biol. Chem. 276, 18243-18248.
66. Liberati, N.T., Datto, M.B., Frederick, J.P., et al. (1999) Smads bind directly to the Jun family of AP-1 transcription factors. Proc. Natl. Acad. Sci. USA 96, 4844-4849.
67. Lin, X., Liang, M. & Feng, X.-H. (2000) Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 inTGF-β signaling. J. Biol. Chem. 275, 36818-36822.
68. Liu, D., Black, B.L. & Derynck, R. (2001) TGF-β inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev. 15, 2950-2966.
69. Liu, B., Dou, C.L., Prabhu, L. & Lai, E. (1999) FAST-2 is a mammalian winged-helix protein which mediates transforming growth factor β signals. Mol. Cell. Biol. 19, 424-430.
70. Liu, X., Elia, A.E.H., Law, S.F, Golemis, E.A., Farley, J. & Wang, T. (2000) A novel ability of Smad3 to regulate proteasomal degradation of a Cas family member HEF1. EMBOJ. 19, 6759-6769.
71. Liu, F., Massagué, J. & Ruiz i Altaba, A. (1998) Carboxy-terminally truncated Gli3 proteins associate with Smads. Nature Genet. 20, 325-326.
72. Lopez-Rovira, T., Chalaux, E., Rosa, J.L., Bartrons, R. & Ventura, F. (2000) Interaction and functional cooperation of NFκB with Smads. J. Biol. Chem. 275, 28937-28946.
73. Macías-Silva, M., Hoodless, P.A., Tang, S.J., Buchwald, M. & Wrana J.L. (1998) Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J. Biol. Chem. 273, 25628-25636.
74. Massagué, J. (1998) TGF-β signal transduction. Annu. Rev. Biochem. 67, 753-791.
75. Matsuda, T., Yamamoto, T., Muraguchi, A. & Saatcioglu, F. (2001) Cross-talk between transforming growth factor-β and estrogen receptor signaling through Smad3 J. Biol. Chem. 276, 42908-42914.
76. Miura, S., Takeshita, T, Asao, H., et al. (2000) Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA. Mol. Cell. Biol. 20, 9346-9355.
77. Miyazono, K., Kusanagi, K. & Inoue, H. (2001) Divergence and convergence of TGF-β/BMP signaling. J. Cell. Physiol. 187, 265-276.
78. Miyazono, K. & Miyazawa, K. (2002) Id: a target of BMP signaling. Sci. STKE, in press.
79. Miyazono, K., ten Dijke, P. & Heldin, C.-H. (2000) TGF-β signaling by Smad proteins. Adv. Immunol. 75, 115-157.
80. Moustakas, A., Souchelnytskyi, S. & Heldin, C.-H. (2001) Smad regulation in TGF-β signal transduction. J. Cell Sci. 114, 4359-4369.
81. Nakashima, K., Takizawa, T., Ochiai, W., et al. (2001) BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis. Proc. Natl. Acad. Sci. USA 98, 5868-5873.
82. Nicholls, A., Sharp, K.A. & Honig, B. (1991) Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins Struct. Funct. General 11, 282-296.
83. Nishihara, A., Hanai, J.-i., Imamura, T., Miyazono, K. & Kawabata, M. (1999) E1A inhibits transforming growth factor-β signaling through binding to Smad proteins. J. Biol. Chem. 274, 28716-28723.
84. Nishihara, A., Hanai, J.-i., Okamoto, N., et al. (1998) Role of p300, a transcriptional coactivator, in signalling of TGF-β. Genes Cells 3, 613-623.
85. Nishita, H., Hashimoto, M.K., Ogata, S., et al. (2000) Interaction between Wnt and TGF-β signalling pathways during formation of Spemann's organizer. Nature 403, 781-785.
86. Nomura, M. & Li, E. (1998) Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 393, 786-790.
87. Norton, J.D., Deed, R.W, Craggs, G. & Sabilitzky, F. (1998) Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol. 8, 58-65.
88. Oh, S.P., Seki, T., Goss, K.A., et al. (2000) Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA 97, 2626-2631.
89. Waf-1/Cip-1 regulation by transforming growth factor-β. J. Biol. Chem. 275, 29244-29256.
90. Pardali, E., Xie, X.Q., Tsapogas, P., et al. (2000a) Smad and AML proteins synergistically confer transforming growth factor β1 responsiveness to human germ-line IgA genes. J. Biol. Chem. 275, 3552-3560.
91. Pouponnot, C.,Jayaraman, L. & Massagué, J. (1998) Physical and functional interaction of SMADs and p300/CBP. J. Biol, Chem. 273, 22865-22868.
92. Preobrazhenska, O., Yakymovych, M., Kanamoto, T., et al. (2002) BRCA2 and Smad3 synergize in regulation of gene transcription. Oncogene 21, 5660-5664.
93. Qin, B.Y., Chacko, B.M., Lam, S.S., de Caestecker, M.P., Correia, J.J. & Lin, K. (2001) Structural basis of Smad1 activation by receptor kinase phosphorylation. Mol. Cell 6, 1303-1312.
94. Qin, B.Y., Lam, S.S., Correia, J.J. & Lin, K. (2002) Smad3 allostery links TGF-β receptor kinase activation to transcriptional control. Genes Dev. 16, 1950-1963.
95. Quinn, Z.A., Yang, C.-C., Wrana, J.L. & McDermott, J.C. (2001) Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins. Nucl. Acids Res. 29, 732-742.
96. Reissmann, E., Jörnvall, H., Blokzijl, A., et al. (2001) The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. Genes Dev. 15, 2010-2022.
97. Ring, C., Ogata, S., Meek, L., et al. (2002) The role of a Williams-Beuren syndrome-associated helix-loop-helix domain-containing transcription factor in activin/nodal signaling. Genes Dev. 15, 455-466.
98. Rodriguez, C., Huang, L.J.-S., Son, J.K., McKee, A., Xiao, Z. & Lodish, H.F. (2001) Functional cloning of the proto-oncogene brain factor-1 (BF-1) as a Smad-binding antagonist of transforming growth factor-β signaling. J. Biol. Chem. 276, 30224-30230.
99. Rosen, V. & Wozney, J.M. (2002) Bone morphogenetic proteins. In: Principles of Bone Biology (eds J.P. Bilezikian, L.G. Raisz, G.A. Rodan, et al.), 2nd edn, pp. 919-928. San Diego: Academic Press.
100. Sano, Y., Harada, J., Tashiro, S., Gotoh-Mandeville, R., Maekawa, T. & Ishii, S. (1999) ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-β signaling. J. Biol. Chem. 274, 8949-8957.
101. Sasaki, A., Masuda, Y., Ohta, Y., Ikeda, K. & Watanabe, K. (2001) Filamin associates with Smads and regulates transforming growth factor-β signaling. J. Biol. Chem. 274, 17871-17877.
102. Scherer, A. & Graff, J.M. (2000) Calmodulin differentially modulates Smad1 and Smad2 signaling. J. Biol. Chem. 275, 41430-41438.
103. Shen, X., Hu, P.P., Liberati, N.T., Datto, M.B., Frederick, J.P & Wang, X.-F. (1998) TGF-β-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein. Mol. Biol. Cell 9, 3309-3319.
104. Shi, X., Bai, S., Li, L. & Cao, X. (2001) Hoxa-9 represses TGF-β-induced osteopontin gene transcription. J. Biol. Chem. 276, 850-855.
105. Shi, X., Yang, X., Chen, D., Chang, D. & Cao, X. (1999) Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling. J. Biol. Chem. 274, 13711-13717.
106. Shimizu, K., Bourillot, P.-Y., Nielsen, S.J., Zorn, A. & Gurdon, J.B. (2001) Swift is a novel BRCT domain coactivator of Smad2 in transforming growth factor β signaling. Mol. Cell. Biol. 21, 3901-3912.
107. Shioda, T., Lechleider, R.J., Dunwoodie, S.L., et al. (1998) Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator. Proc. Natl. Acad. Sci. USA 95, 9785-9790.
108. Song, C.Z., Tian, X. & Gelehrter, T.D. (1999) Glucocorticoid receptor inhibits transforming growth factor-β signaling by directly targeting the transcriptional activation function of Smad3. Proc. Natl. Acad. Sci. USA 96, 11776-11781.
109. Stroschein, S.L., Wang, W., Zhou, S., Zhou, Q. & Luo, K. (1999) Negative feedback regulation of TGF-Β signaling by the SnoN oncoprotein. Science 286, 771-774.
110. Stroschein, S.L., Bonni, S., Wrana, J.L. & Luo, K. (2001) Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. Genes Dev. 15, 2882-2886.
111. Thompson, J.D., Higgins, D.G. & Gibson, T.J. (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl. Acids Res. 22, 4673-4680.
112. Topper, J.N., DiChiara, M.R., Brown, J.D., et al. (1998) CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor β transcriptional responses in enclothetial cells. Proc. Natl. Acad. Sci. USA 95, 9506-9511.
113. Tsukazaki, T., Chiang, T.A., Davison, A.F., Attisano, L. & Wrana, J.L. (1998) SARA, a FYVE domain protein that recruits Smad2 to the TGFβ receptor. Cell 11, 779-791.
114. Verschueren, K., Remacle, J.E., Collart, C., et al. (1999) SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5′-CACCT sequences in candidate target genes. J. Biol. Chem. 274, 20489-20498.
115. Visser, J.A., Olaso, R., Verhoef-Post, M., Kramer, P., Themmen, A.P.N. & Ingraham, H.A. (2001) The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling. Mol. Endocrinol. 15, 936-945.
116. Wan, M., Cao, X., Wu, Y, et al. (2002) Jab1 antagonizes TGF-β signaling by inducing Smad4 degradation. EMBO Report 3, 171-176.
117. Wang, W., Mariam, E.V., Harland, R.M. & Luo, K. (2000) Ski represses bone morphogenetic protein signaling in Xenopus and mammalian cells. Proc. Natl. Acad. Sci. USA 97, 14393-14399.
118. Wotton, D., Lo, R.S., Lee, S. & Massagué, J. (1999) A Smad transcriptional corepressor. Cell 97, 29-39.
119. Wrana, J.L., Attisano, L., Wieser, R., Ventura, F. & Massagué, J. (1994) Mechanism of activation of the TGF-β receptor. Nature 370, 341-347.
120. Wu, J.W, Hu, M., Chai, J., et al. (2001) Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-β signaling. Mol. Cell 8, 1277-1289.
121. Wurthner, J.U., Frank, D.B., Felici, A., et al. (2001) Transforming growth factor-β receptor-associated protein 1 is a Smad4 chaperone. J. Biol. Chem. 276, 19495-19502.
122. Xiao, Z., Liu, X. & Lodish, H.F. (2000) Importin β mediates nuclear translocation of Smad 3. J. Biol. Chem. 275, 23425-23428.
123. Yagi, K., Furuhashi, M., Aoki, H., et al. (2002) c-myc is a downstream target of Smad pathway. J. Biol. Chem. 277, 854-861.
124. Yamakawa, N., Tsuchida, K. & Sugino, H. (2002) The ras GAP-binding protein, Dok-1, mediates activin signaling via serine/threonine kinase receptors. EMBO J. 21, 1684-1694.
125. Yamamoto, T.S., Takagi, C., Hyodo, A.C. & Ueno, N. (2001) Suppression of head formation by Xmsx-1 through the inhibition of intracellular nodal signaling. Development 128, 2769-2779.
126. Yanagisawa, J., Yanagi, Y., Masuhiro, Y., et al. (1999) Convergence of transforming growth factor-β and vitamin D signaling pathways on SMAD transcriptional coactivators. Science. 283, 1317-1321.
127. Yang, X., Letterio,J.J., Lechleider, R.J., et al. (1999) Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J. 18, 1280-1291.
128. Yokota, Y. & Mori, S. (2002) Role of Id family proteins in growth control. J. Cell. Physiol. 190, 21-28.
129. Yoshida, Y., Tanaka, S., Umemori, H., et al. (2000) Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 103, 1085-1097.
130. Zawel, L., Le Dai, J., Buckhaults, P., et al. (1998) Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1, 611-617.
131. Zhang, Y., Chang, C., Gehling, D.J., Hemmati-Brivanlou, A. & Derynck, R. (2001) Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc. Natl. Acad. Sci. USA 98, 974-979.
132. Zhang, Y., Feng, X.-H. & Derynck, R. (1998) Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature 394, 909-913.
133. Zhu, H., Kavsak, P., Abdollah, S., Wrana,J.L. & Thomsen, G.H. (1999) A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400, 687-693.
134. Zhu, Y., Richardson, J.A., Parada, L.F. & Graff, J.M. (1998) Smad3 mutant mice develop metastatic colorectal cancer. Cell 94, 703-714.
135. Zimmerman, C.M., Kariapper, M.S. & Mathews, L.S. (1998) Smad proteins physically interact with calmodulin. J. Biol. Chem. 273, 677-680.
136. Zimmers, T.A., Davies, M.V., Koniaris, L.G., et al. (2002) Induction of cachexia in mice by systemically administered myostatin. Science 296, 1486-1488.